Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 inhibitors in the pipeline: Promise and progress.
Vanella V, Festino L, Strudel M, Simeone E, Grimaldi AM, Ascierto PA. Vanella V, et al. Among authors: grimaldi am. Oncoimmunology. 2017 Sep 21;7(1):e1365209. doi: 10.1080/2162402X.2017.1365209. eCollection 2017. Oncoimmunology. 2017. PMID: 29296516 Free PMC article. Review.
Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma.
Simeone E, Grimaldi AM, Ascierto PA. Simeone E, et al. Among authors: grimaldi am. Melanoma Manag. 2015 Feb;2(1):41-50. doi: 10.2217/mmt.14.30. Epub 2015 Feb 25. Melanoma Manag. 2015. PMID: 30190830 Free PMC article. Review.
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.
Madonna G, Ballesteros-Merino C, Feng Z, Bifulco C, Capone M, Giannarelli D, Mallardo D, Simeone E, Grimaldi AM, Caracò C, Botti G, Fox BA, Ascierto PA. Madonna G, et al. Among authors: grimaldi am. Oncoimmunology. 2018 Sep 5;7(12):e1405206. doi: 10.1080/2162402X.2017.1405206. eCollection 2018. Oncoimmunology. 2018. PMID: 30524879 Free PMC article.
Marker utility for combination therapy.
Simeone E, Grimaldi AM, Ascierto PA. Simeone E, et al. Among authors: grimaldi am. Methods Mol Biol. 2014;1102:97-115. doi: 10.1007/978-1-62703-727-3_7. Methods Mol Biol. 2014. PMID: 24258976 Review.
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA. Grimaldi AM, et al. Oncoimmunology. 2014 May 14;3:e28780. doi: 10.4161/onci.28780. eCollection 2014. Oncoimmunology. 2014. PMID: 25083318 Free PMC article.
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.
Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, Camerlingo R, Capone M, Madonna G, Festino L, Caracò C, Di Monta G, Marone U, Di Marzo M, Grimaldi AM, Mori S, Ciliberto G, Ascierto PA. Mozzillo N, et al. Among authors: grimaldi am. Oncoimmunology. 2015 May 22;4(6):e1008842. doi: 10.1080/2162402X.2015.1008842. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155423 Free PMC article.
170 results